Our latest Kolling Institute newsletter is out detailing the very latest updates from our expert team of researchers, including some promising progress with our bowel cancer investigators.  There's an opportunity to join a clinical trial to minimise the impact of osteoarthritis, a new approach to reduce spinal cord injury related pain and an international award recognising 40 years of service .....
Read more

Bowel cancer is the third most common type of cancer in Australia and treating it is both costly and complex. Alarmingly, rates are rising among people under 50, and researchers still don’t know why. It is for these reasons that Professor Mark Molloy is on a mission to prevent the disease in the first place. Based in the Kolling Institute, the leading bowel cancer research specialist is runnin.....
Read more

 A fascinating and informative podcast has been launched showcasing groundbreaking research, innovative healthcare, and inspiring stories from across Northern Sydney. Tomorrow’s Medicine Today is an initiative of the Northern Sydney Local Health District and the Kolling Institute, New South Wales’ oldest medical research institute. Co-hosted by the Kolling Institute’s Academic Director Profess.....
Read more

The inaugural Eva Kolling Research Day was staged within Royal North Shore Hospital, providing the perfect chance to celebrate the vision and generosity of a true pioneer. Established in 1920, the Kolling Institute is the oldest medical research institute in New South Wales. It has been at the forefront of cutting-edge research for more than a hundred years, with its founding director Dr W. Wilson .....
Read more

Researchers from Royal North Shore Hospital and the Kolling Institute will lead Australia’s first study of whole-body screening for young people with neurofibromatosis type 1. Led by Dr Sue-Faye Siow from the department of clinical genetics, the study was awarded a grant through the RNSH Campus Research Grants Scheme, and an additional $30,000 in support from the NORTH Foundation. Neurofibromatosis.....
Read more

International Clinical Trials Day provided the chance to recognise the many people contributing to our life-changing clinical trials. Two key events were staged to mark the day, including a presentation in the Kolling auditorium from leading clinical trial investigators, and a public display within Royal North Shore Hospital.  More than 300 trials are underway across Northern Sydney including .....
Read more

Check out our latest newsletter Researchers target sleep for muscle pain relief Landmark clinical trial to improve lung cancer treatment Pioneering Muscle Map project receives funding support Travel awards for emerging research leaders And much more:  Click here:
Read more

Leading Royal North Shore Hospital clinician researcher Professor Nick Pavlakis and Professor Ben Solomon have secured a $14.7 million MRFF grant for a clinical trial which will explore the use of a liquid biopsy to inform treatment for lung cancer. The condition is the leading cause of cancer death in Australia and worldwide, claiming an estimated 9,000 lives in Australia each year. The pioneering.....
Read more

A two-decade long commitment to reducing blood cancers has delivered coveted national funding to Associate Professor Jenny Wang to progress her vital cancer research. As the head of the Kolling Institute’s Cancer and Stem Cell Laboratory, Associate Professor Wang has secured a $2.95 million investigator grant from the National Health and Medical Research Council to advance her pioneering research i.....
Read more

A special visit by two international cancer specialists could mark the start of a valuable collaborative partnership. Professor Matthew Katz from the MD Anderson Cancer Centre in Houston Texas is recognised as a pioneer in the treatment of pancreatic cancer, while Professor Cynthia Sears from the Johns Hopkins University School of Medicine in Baltimore is a global leader in colorectal cancer resear.....
Read more